Fortis Healthcare Ltd (FORTIS)

Fortis Healthcare Achieves Impressive Annual EPS Growth - 25 Apr, 2024

Fortis Healthcare has achieved an impressive annual EPS growth of 44% over the last three years, with a solid revenue growth of 12% to ₹67b. Insiders have a significant amount of capital invested in it, currently valued at ₹16b. Based on its parts, Fortis Healthcare is worth watching closely.

Fortis Healthcare Launches Adayu Mindfulness for Comprehensive Mental Healthcare - 24 Apr, 2024

Fortis Healthcare has launched Adayu Mindfulness, a vertical for comprehensive mental healthcare in collaboration with United We Care and Adayu. The AI-powered holistic mental health solution will enhance accessibility of care for individuals everywhere, powered by Adayus trained team of mental health experts to provide holistic care.

Fortis Healthcare Launches Multi-Specialty Tertiary Care Hospital in Bengaluru - 19 Apr, 2024

Fortis Healthcare has launched a state-of-the-art, multi-specialty tertiary care hospital in Nagarbhavi, Bengaluru. The healthcare player invested about Rs 6-7 crore in the upgrade of the facility and aims to expand its bed count to 100 from the existing 80 beds amid a rising patient base. Fortis aims for an expansion to 10,000 beds from 4,500 beds in India over the next five to seven years.

Fortis Healthcare Stock Delivers Flattish Returns - 16 Apr, 2024

Ace investor Rakesh Jhunjhunwala holds 4.1% stake in Fortis Healthcare, which has delivered flattish returns by rising just 0.4% year-to-date. In the last six months, the stock is up about 31%.

Fortis Healthcare CEO Outlines Strategy for Sustained Profitability - 12 Apr, 2024

In an interview, Fortis Healthcare CEO Ashutosh Raghuvanshi discussed the company's plans to maximize potential of existing hospitals, expand bed capacity and refine specialties. He also emphasized competition's role in promoting transparency and clinical excellence.

Fortis Healthcare's High P/E Ratio Explained by Forecasted Earnings Growth - 03 Apr, 2024

Fortis Healthcare's high P/E ratio of 58.4x is due to forecasted earnings growth that's higher than the broader market, with estimates suggesting a 39% growth over the next year. While this may justify the current P/E ratio, it's important to note that Fortis Healthcare has been relatively sluggish in terms of earnings growth compared to other companies. It remains to be seen if the company can deliver on its projected growth and maintain its high valuation.